Stockreport

Merck upgraded on post-Keytruda growth, AbbVie cut as upside baked in - Wolfe [Yahoo! Finance]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF underestimating Merck's ability to grow beyond Keytruda and has already priced in much of AbbVie's near- and medium-term upside. Wolfe upgraded Merck to Outperform fro [Read more]